Ofloxacin ophthalmic Pregnancy and Breastfeeding Warnings
Ofloxacin ophthalmic is also known as: Ocuflox
Ofloxacin ophthalmic Pregnancy Warnings
Ofloxacin ophthalmic has been assigned to pregnancy category C by the FDA. Animal studies using high doses have revealed evidence of fetotoxicity and skeletal defects. There are no controlled data in human pregnancy. Cartilage damage and arthropathy are reported in immature animals giving rise to concern over effects on bone formation in the developing fetus. Ofloxacin ophthalmic is only recommended for use during pregnancy when benefit outweighs risk.
Ofloxacin ophthalmic Breastfeeding Warnings
There are no data on the excretion of ofloxacin ophthalmic into human milk. Systemically administered ofloxacin is excreted into breast milk at levels similar to those in plasma. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue the drug or to discontinue nursing, taking into account the importance of the drug to the mother.
See Also...
- Ofloxacin use while Breastfeeding (in more detail)
- ofloxacin drops Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
